Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jan;35(1):1-7.
doi: 10.1007/s13277-013-1076-5. Epub 2013 Aug 14.

The circadian clock and the hypoxic response pathway in kidney cancer

Affiliations
Free article
Review

The circadian clock and the hypoxic response pathway in kidney cancer

Gianluigi Mazzoccoli et al. Tumour Biol. 2014 Jan.
Free article

Abstract

The most frequent malignant tumor of the kidney in adults is represented by renal cell carcinoma characterized by high lethality related to presence of metastatic disease at the time of diagnosis. The main characteristic molecular feature of most sporadic renal cell carcinomas is the mutation of the tumor suppressor gene encoding the von Hippel-Lindau protein, with alteration of regulated pathways and activation of hypoxia-inducible transcription factors. Hypoxia-inducible transcription factors are transcriptional regulators of genes controlling mammalian oxygen homeostasis, energy metabolism, neovascularisation, internal pH, cell survival, and migration and are considered powerful promoters of tumor growth. Tight interrelationships have been evidenced between hypoxic response pathway and circadian pathway. Severe deregulation of genes involved in the circadian clock circuitry and response to hypoxia has been found in patients affected by kidney cancer, influencing the process of carcinogenesis, as well as disease progression and outcome. The study of alterations of clock gene expression and hypoxia correlated pathway in kidney cancer may promote the comprehension of pathophysiological mechanisms involved in renal cell carcinoma onset and evolution and may help to exploit more effective therapeutic approaches.

PubMed Disclaimer

References

    1. IUBMB Life. 2008 Sep;60(9):591-7 - PubMed
    1. J Biol Chem. 2008 Feb 22;283(8):4535-42 - PubMed
    1. Oncogene. 1998 Jun 18;16(24):3215-8 - PubMed
    1. J Mol Cell Cardiol. 2003 May;35(5):473-81 - PubMed
    1. Eur Urol. 2011 Jan;59(1):120-7 - PubMed

Publication types

MeSH terms

LinkOut - more resources